InvestorsHub Logo
Followers 79
Posts 24524
Boards Moderated 1
Alias Born 09/08/2000

Re: None

Wednesday, 10/16/2019 8:36:55 AM

Wednesday, October 16, 2019 8:36:55 AM

Post# of 27431
ALRN - .43891 Pre-market now at .535/.54

Aileron Therapeutics Announces the Initiation of Patient Treatment in its First Clinical Ph1b/2 Trial of ALRN-6924 as a Myelopreservation Agent

https://www.tradescores.com/StockReport/alrn

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.